CAS 1208076-11-2

2-bromo-3,6-difluoroanisole

Description:

2-Bromo-3,6-difluoroanisole is an organic compound characterized by the presence of a bromine atom and two fluorine atoms on a methoxy-substituted aromatic ring. Its molecular structure features a benzene ring with a methoxy group (-OCH3) and halogen substituents, which influence its chemical reactivity and physical properties. The presence of the bromine and fluorine atoms typically enhances the compound's lipophilicity and may affect its biological activity, making it of interest in pharmaceutical and agrochemical research. The compound is likely to exhibit moderate to high stability under standard conditions, but its reactivity can be influenced by the electronegative halogen substituents. Additionally, 2-bromo-3,6-difluoroanisole may participate in various chemical reactions, including nucleophilic substitutions and electrophilic aromatic substitutions, due to the electron-withdrawing nature of the halogens. Its specific applications and behavior in reactions would depend on the context of its use, such as in synthesis or as an intermediate in chemical processes.

Synonyms:

• Benzene, 2-bromo-1,4-difluoro-3-methoxy-
• 2-bromo-1,4-difluoro-3-methoxybenzene
• 2-Bromo-3,6-difluoroanisole

2-Bromo-1,4-difluoro-3-methoxybenzene

CAS: 1208076-11-2

Formula: C₇H₅BrF₂O

Purity: 95%

Molecular weight: 223.0148

Ref: IN-DA0091KP

2-Bromo-1,4-difluoro-3-methoxybenzene

CAS: 1208076-11-2

2-Bromo-1,4-difluoro-3-methoxybenzene

Purity: 95%

Molecular weight: 223.01g/mol

Ref: 54-PC250039

2-Bromo-3,6-difluoroanisole

CAS: 1208076-11-2

Formula: C₇H₅BrF₂O

Purity: 97.0%

Color and Shape: Clear

Molecular weight: 223.017

Ref: 10-F038263

2-Bromo-1,4-difluoro-3-methoxybenzene

CAS: 1208076-11-2

2-Bromo-1,4-difluoro-3-methoxybenzene (BDFMB) is a radiolabeled metabotropic glutamate receptor 2 (mGlu2) allosteric modulator. BDFMB has been shown to have affinity for the mGlu2 receptor and is able to increase the binding of glutamate to this receptor. This drug may be useful in clinical studies as a radiotracer for imaging mGlu2 receptors in the brain. It has also been shown to be an allosteric modulator of the mGlu2 receptor, which may provide a new therapeutic option for treating depression and other disorders that are thought to involve mGlu2 receptors.

Formula: C₇H₅BrF₂O

Purity: Min. 95%

Molecular weight: 223.01 g/mol

Ref: 3D-IYB07611